Singapore markets closed

Sabra Health Care REIT, Inc. (SBRA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
13.94+0.29 (+2.12%)
At close: 04:00PM EDT
13.53 -0.41 (-2.94%)
After hours: 04:55PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.23B
Enterprise value 5.60B
Trailing P/E 232.33
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.01
Price/book (mrq)1.15
Enterprise value/revenue 8.65
Enterprise value/EBITDA 17.96

Trading information

Stock price history

Beta (5Y monthly) 1.17
52-week change 322.71%
S&P500 52-week change 322.36%
52-week high 314.91
52-week low 310.30
50-day moving average 314.04
200-day moving average 313.70

Share statistics

Avg vol (3-month) 32.09M
Avg vol (10-day) 31.91M
Shares outstanding 5231.48M
Implied shares outstanding 6231.48M
Float 8228.1M
% held by insiders 11.23%
% held by institutions 194.33%
Shares short (15 Apr 2024) 411.34M
Short ratio (15 Apr 2024) 46.2
Short % of float (15 Apr 2024) 47.03%
Short % of shares outstanding (15 Apr 2024) 44.90%
Shares short (prior month 15 Mar 2024) 412.39M

Dividends & splits

Forward annual dividend rate 41.2
Forward annual dividend yield 48.61%
Trailing annual dividend rate 31.20
Trailing annual dividend yield 38.79%
5-year average dividend yield 49.06
Payout ratio 42,000.00%
Dividend date 329 Feb 2024
Ex-dividend date 412 Feb 2024
Last split factor 21:3
Last split date 316 Nov 2010

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 2.13%
Operating margin (ttm)32.93%

Management effectiveness

Return on assets (ttm)2.45%
Return on equity (ttm)0.47%

Income statement

Revenue (ttm)644.62M
Revenue per share (ttm)2.79
Quarterly revenue growth (yoy)93.30%
Gross profit (ttm)N/A
EBITDA 395.89M
Net income avi to common (ttm)13.76M
Diluted EPS (ttm)0.06
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)60.2M
Total cash per share (mrq)0.26
Total debt (mrq)2.43B
Total debt/equity (mrq)86.59%
Current ratio (mrq)0.48
Book value per share (mrq)12.12

Cash flow statement

Operating cash flow (ttm)300.57M
Levered free cash flow (ttm)245.38M